. UV absorption (a, c, e, g, i, k) and raw fluorescence emission (b, d, f, h, j, l) spectra of BSA (4 M) with increasing amounts of copper, norfloxacin and copper complexes. (a, b) norfloxacin; (c, d) copper(II);
(e, f) Cu(bipy); (g, h) complex (1); (i, j) Cu(phen); (k, l) complex (2). The fluorescence peak around 400 nm is due to direct excitation of NOR dissociated from Cu(II). (e, f) Cu(bipy); (g, h) complex (1); (i, j) Cu(phen); (k, l) complex (2). The fluorescence peak around 400 nm is due to direct excitation of NOR dissociated from Cu(II). where F corr and F obs are the corrected and observed fluorescence intensity, A ex and A em are the absorbance at the excitation and emission wavelengths, respectively, and the optical path in cm, , is equal to 1. The corrected fluorescence emission spectra appear as solid lines in (b). Note that the fluorescence spectrum of BSA in the presence of complex 1 (red dashed line) not only has a lower intensity, but is also distorted because of complex 1 absorption in the region between 300 and 350 nm. (1); (e) Cu(phen); (f) complex (2). The fluorescence peak around 400 nm is due to direct excitation of NOR dissociated from the Cu(II) complexes. Legends for the quencher concentrations are the same, except for (e).
